Skip to content

English

Leptomeningeal Metastases
CNSide® CSF Assay
News & FAQs
Company
Contact Us

Leptomeningeal Metastases
CNSide® CSF Assay
News & FAQs
Company
Contact Us
English
Order a Test

Order a Test

How can we help you?

There are no suggestions because the search field is empty.

Resources
FAQs

FAQs

Insurance Coverage
Our Laboratory
Process & Reporting
Intended Use & Specifications
Clinical Validation
Technology

FAQs

Leptomeningeal Metastases
CNSide® CSF Assay
News & FAQs
Company
Contact Us

© 2026 CNSide Diagnostics, LLC is a subsidiary of Plus Therapeutics, Inc. CNSide is a trademark of CNSide Diagnostics, LLC. All rights reserved.

The intended use of this test is to establish the presence and quantity of tumor cells in cerebrospinal fluid specimens of patients with Leptomeningeal Disease. This test was developed and its performance characteristics determined by CNSide Diagnostics LLC. It has not been cleared or approved by the FDA. This test is used for clinical purposes and should not be regarded as investigational or for research. CNSide Diagnostics laboratory is certiﬁed under the Clinical Laboratory Improvement Amendments (CLIA) as qualiﬁed to perform high complexity clinical laboratory testing.